Cost-Effectiveness Analyses and Cost Analyses in Castration-Resistant Prostate Cancer: A Systematic Review

PLoS ONE - United States
doi 10.1371/journal.pone.0208063
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Cost-Effectiveness Analyses

1966English

Getting the Cost Right in Cost-Effectiveness Analyses

American Journal of Psychiatry
PsychiatryMental Health
1997English

Pcn153 - Cost-Effectiveness Analysis of Apalutamide for Treatment in Non- Metastasis Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Quality of Reporting Methods and Results of Cost-Effectiveness Analyses in Spain: A Methodological Systematic Review

Systematic Reviews
Medicine
2016English

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cost-Effectiveness and Cost-Benefit Analyses for Public Health Programs

Public Health Reports (1896-1970)
1968English

Cost-Effectiveness Analyses of Training: A Manager’s Guide

Human Resources for Health
EnvironmentalPublic HealthPublic AdministrationOccupational Health
2013English

A Systematic Review and Methodological Evaluation of Published Cost-Effectiveness Analyses of Aromatase Inhibitors Versus Tamoxifen in Early Stage Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy